PROFOUND MEDICAL CORP. Repayments of Long-Term Debt
PROFOUND MEDICAL CORP. (PROF) reported Repayments of Long-Term Debt of $290.00 thousand for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-06
- PROFOUND MEDICAL CORP. repayments of long-term debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PROFOUND MEDICAL CORP. repayments of long-term debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PROFOUND MEDICAL CORP. repayments of long-term debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PROFOUND MEDICAL CORP. repayments of long-term debt for the quarter ending 2025-03-31 was $290.00K, a 53.45% decline year-over-year.
- PROFOUND MEDICAL CORP. repayments of long-term debt for fiscal 2023 was $912.00K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $290.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $290.00K 10-Q · filed 2025-11-13 | $449.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $290.00K 10-Q · filed 2026-08-06 | $449.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.04M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $290.00K 10-Q · filed 2026-05-07 | $449.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.04M derived: sum of 3 quarters · filed 2026-05-07 | $1.65M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $159.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-13 | $751.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.35M derived: sum of 3 quarters · filed 2025-11-13 | $1.98M 10-Q · filed 2025-11-13 | $2.56M 10-K · filed 2025-03-07 |
| 2024-09-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.20M derived: sum of 2 quarters · filed 2025-11-13 | $1.82M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.23M 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $623.00K 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | $912.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |